Clinical review benefits from access to detailed evidence, but that access must serve a defined purpose. A workspace should help qualified users examine records without making sensitive information unnecessarily available. Convenience and governance need to be designed together.
The FDA’s electronic systems guidance provides clinical-investigation context. The practices below are proposed design considerations, with applicable legal, contractual, and organizational requirements determining the final controls.
1. Define the permitted use
Specify the study, users, data types, and review activities supported by the workspace. Identify whether identifiable, coded, or otherwise transformed data are needed. Do not assume that removing a name removes every disclosure risk from a detailed clinical history.
The HHS de-identification guidance describes HIPAA approaches where that framework applies. It should not be treated as a universal determination for every jurisdiction or as a claim that a particular dataset is anonymous.
2. Test access with realistic tasks
Assign permissions according to role and scope. Review blinded and unblinded information separately. Check what a user can view, query, export, and share, including material produced indirectly through analysis or generated summaries.
For a hypothetical external reviewer, access to an aggregate safety report may be appropriate while unrestricted participant-level exploration is not. Test the actual task rather than relying only on the names of permission groups.
3. Preserve accountability
Maintain appropriate records of relevant actions and changes. Determine which activities need reviewable audit information and how that information is retained and retrieved. A log is useful only if it supports the organization’s oversight needs and can be interpreted.
ICH E6(R3) is additional reading for clinical-trial data governance. Our recommendation is to include retrieval, role changes, and incident handling in acceptance exercises, not only routine analysis generation.
4. Evaluate exports and integrations
A controlled interface can still leak its intended boundaries when users export results or connect an external service. Examine whether identifiers, hidden columns, embedded metadata, or prompts carry sensitive information beyond the intended context.
Review integrations according to their actual data flows, retention arrangements, and approved purpose. When an AI service is involved, determine what information it receives and what controls govern storage and subsequent use.
A strong workspace makes permitted review straightforward and unauthorized exposure difficult. It preserves enough evidence for analysis and oversight while keeping purpose, access, and accountability visible. Governance should be part of the workflow users experience, not a separate document that the interface quietly undermines.
